Skip to content
Blackberry Empire – Lifestyle
Author:
Vivos Therapeutics, Inc
Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel
October 19, 2026
Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test
October 15, 2026
Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives
September 29, 2026
Vivos Therapeutics Reduces Debt, Boosts Equity for Nasdaq Compliance
September 8, 2026
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
August 29, 2026
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment
August 20, 2026
Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update
August 14, 2026
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
August 14, 2026
Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations
August 11, 2026
Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology
August 5, 2026
1
2
Next Page
→